Formlabs, University of South Florida Health, Northwell Health and Tampa General Hospital joined forces to create 3D printed nasal swabs to test for COVID-19 in patients in emergency shortage situations.
In addition, the FDA granted Formlabs emergency clearance for 3D-printed ventilator component.
GreenLight Biosciences is expanding their vaccine efforts to establish a scalable current Good Manufacturing Practices (cGMP) manufacturing platform to allow for the production of almost any RNA-based COVID-19 vaccine at a scale and cost that enables global delivery. In addition, they are advancing a number of RNA-based vaccines and therapeutics against COVID-19.
Hollingsworth & Vose (H&V) provides products that are critical to responding to the COVID-19 pandemic, including filtration media for N95 respirators, ventilator filtration media, materials used in the production of medical gowns and surgical hoods, and consumables for COVID-19 test systems.
Eli Lilly and Co. reached an agreement with the National Institutes of Health to study one of its drugs as a COVID-19 treatment. The drug is approved in more than 65 countries as a treatment for adults with moderately to severely active rheumatoid arthritis.
They also opened labs and planned drive-thrus to help boost Indiana's COVID-19 testing capacity.
After recently starting human trials for a COVID-19 vaccine, Moderna was featured on 60 minutes.
Since then, their potential coronavirus vaccine got $483 million boost from Feds.
Moderna announced positive interim Phase 1 data for its mRNA vaccine (mRNA-1273) against novel coronavirus.
NOBULL is donating thousands of CDC recommended face masks to medical professionals. They were able to access the masks from an FDA registered factory through their partners. They are accepting donations to procure face masks or other PPE for medical professionals.
Pfizer and BioNTech are co-developing a potential COVID-19 vaccine.
Pfizer and the Pfizer Foundation have also announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the US and around the world.
The sweeping impacts of COVID-19 are immeasurable and, at times, defeating. We have taken solace in the fact that people across the globe are coming together (while remaining socially distant) to help address and overcome this pandemic. As a firm, we feel incredibly fortunate to support clients across industries and geographies–some of whom were part of the earliest adopters in shifting gears and focusing on efforts to combat coronavirus.
During this unprecedented time, we want you to know that we are still here to help. We vow to provide you with the high level of service you deserve, and we will do everything we can to have a positive impact on you. We want our clients to be able to focus on their families and know their IP interests are safe with us.
Our sincere thoughts are with those impacted by the virus.
Mechanical Technologies Chair
Electrical Computer Technologies Chair
Chemical & Material Technologies Chair
Trademark & Copyright Chair